Association of Biotechnology Led Enterprises

News

Baylor College of Medicine collaborates with Biological E. to develop a covid-19 vaccine for global access

The licensing agreement signed in August is for the development of a safe, effective and affordable COVID-19 vaccine.

Sep 03, 2020

By : Team ABLE

Bharat Biotech Prepares for Phase 2 human clinical trials of Covaxin

Phase 1 human trial encountered ‘no side effects’: Dr E Venkata Rao, Principal Investigator

Sep 03, 2020

By : Team ABLE

GSK and Vir Biotechnology start Phase 2/3 study of COVID-19 Antibody Treatment

Phase 2/3 COMET-ICE study will investigate the safety and efficacy of antibody treatment in preventing hospitalization due to COVID-19

Sep 03, 2020

By : Team ABLE

Oxford COVID-19 vaccine enters Phase III clinical trials in US

The trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19 AZD1222 supported by safety and immunogenicity across all adult age groups

Sep 03, 2020

By : Team ABLE

Winning Over Covid-19: Dr Kiran Mazumdar-Shaw’s Experience

ABLE non-executive Chairperson and Biocon executive chairperson Kiran Mazumdar-Shaw, who recently tested COVID-19 positive and recovered subsequently, says that leveraging science to manage the virus is the only reliable way ahead. Here is the first person account from her blog.

Sep 03, 2020

By : Kiran Mazumdar-Shaw